Cargando…
Oral antiplatelet therapy and platelet inhibition: An experience from a tertiary care center
AIMS AND OBJECTIVES: Although clopidogrel combined with aspirin is the most commonly used dual drug combination to avert thrombotic events in patients with coronary artery disease, the poor responsiveness to clopidogrel remains a concern. The objective of the current study is to assess the extent of...
Autores principales: | Dalal, Jamshed J., Digrajkar, Aarti, Gandhi, Alap |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079129/ https://www.ncbi.nlm.nih.gov/pubmed/27773400 http://dx.doi.org/10.1016/j.ihj.2015.12.022 |
Ejemplares similares
-
ST2 elevation in heart failure, predictive of a high early mortality
por: Dalal, Jamshed J., et al.
Publicado: (2018) -
Platelets: Pathophysiology and Antiplatelet Drug Therapy
por: Snyder, Edward L.
Publicado: (1983) -
Platelet Function Testing-Guided Antiplatelet Therapy
por: Lenk, Ekaterina, et al.
Publicado: (2014) -
Thromboelastography With Platelet Mapping is Not an Effective Measure of Platelet Inhibition in Patients With Spontaneous Intracerebral Hemorrhage on Antiplatelet Therapy
por: Lam, Helena, et al.
Publicado: (2018) -
Antiplatelet Agents Inhibit the Generation of Platelet-Derived Microparticles
por: Giacomazzi, Alice, et al.
Publicado: (2016)